Medical Bulletin 13/November/2025 Anshika Mishra13 Nov 2025 2:55 PM ISTHere are the top medical news for the day:New Study Reveals Unexpected Link Between Sugar Metabolism and Alcohol Addiction Scientists from the...
Study Reveals Prostate Cancer's Hidden Weak Spot, Two Key Enzymes Identified Anshika Mishra13 Nov 2025 8:45 AM ISTScientists have discovered a critical weakness in prostate cancer cells involving two enzymes, PDIA1 and PDIA5, that protect the androgen receptor...
Study confirms sustained reduction in prostate cancer mortality with PSA screening Dr. Kamal Kant Kohli12 Nov 2025 8:30 PM ISTThe European Randomized Study of Screening for Prostate Cancer (ERSPC) sheds new light on the long-term impact of prostate-specific antigen (PSA)...
CDSCO Panel Clears MSN Labs' Abiraterone Acetate 1000 mg, Mandates Phase IV Trial Parthika Patel10 Nov 2025 8:38 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology, under the Central Drugs Standard Control Organisation (CDSCO), has recommended the grant of...
Zydus Lifesciences bags tentative USFDA nod for cancer drug Olaparib Ruchika Sharma7 Nov 2025 6:23 PM ISTAhmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) for Olaparib ...
Lower dose of abiraterone acetate also effective for prostate cancer treatment, suggests research Dr. Kamal Kant Kohli2 Nov 2025 8:30 PM ISTPharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH)...
Statin Use Not Linked to Lower Prostate Cancer Risk, but Genetic Variants May Influence Outcomes: Study Suggests Medha Baranwal2 Nov 2025 2:23 PM ISTCanada: A recent study published in Prostate Cancer and Prostatic Diseases sheds new light on the debated role of statins in prostate cancer...
GSK acquires exclusive rights from Syndivia for antibody drug conjugate in prostate cancer Ruchika Sharma28 Oct 2025 10:30 AM ISTLondon: GSK plc and Syndivia, a private biotechnology company focused on next-generation ADCs, have announced an agreement granting GSK exclusive...
Drug combo cuts risk of death in advanced prostate cancer by 40%: NEJM Dr. Kamal Kant Kohli27 Oct 2025 10:00 PM ISTMen whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the...
Medical Bulletin 17/October/2025 Anshika Mishra17 Oct 2025 3:00 PM ISTHere are the top medical news for the day:Is Social Isolation an Overlooked Risk Factor in Cancer Mortality? People with cancer who experience...
JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer Ruchika Sharma17 Oct 2025 11:43 AM ISTHorsham: Johnson and Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the company for its...
New Imaging Technique Detects Prostate Cancer Recurrence with 70 Percent Accuracy: Study Finds Anshika Mishra17 Oct 2025 8:15 AM ISTA new Canadian study has shown that a novel imaging technique, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scanning,...
